Unnamed: 0_level_0,Unnamed: 1_level_0,Unnamed: 2_level_0,Unnamed: 3_level_0,Unnamed: 4_level_0,Unnamed: 5_level_0,Vascular risk factors,Vascular risk factors,Vascular risk factors,Imaging biomarkers for cSVD,Imaging biomarkers for cSVD,Imaging biomarkers for cSVD,Cognitive outcome
Cohort,"Total sample size, n","Age, years old (mean ± SD)","Sex (F), %","Race/ethnicity, n (%)","Education, years (mean ± SD or n[%])","Diabetes (Y), %","Hypertension (Y), %","Smoking (Y), %",WM‐FW,ALPS index,WMHV,UDS3‐EF scores
MarkVCID,547,72.6 ± 7.2,"331/547, 61%","Non‐Hispanic White: 241/547, 44%;Black/African American: 39/547, 7%;Hispanic ethnicity: 198/547, 36%",15.1 ± 3.5,"87/443, 20%","237/450, 53%","171/447, 38%",0.2 ± 0.05,1.2 ± 0.2,0.004 ± 0.004,−0.6 ± 0.9
UCD_ADRC,342,75.5 ± 7.6,"229/342, 67%","Non‐Hispanic White: 140/342, 41%Black/African American: 91/342, 27%Hispanic ethnicity: 98/342, 29%",14.4 ± 4.1,"111/342, 32%","220/342, 64%","151/342, 44%",0.2 ± 0.05,1.0 ± 0.2,0.007 ± 0.010,−0.9 ± 0.9
UCSF_MAC,179,70.2 ± 10.8,"96/179, 54%","White (no Hispanic/non‐Hispanic distinction): 158/179, 89%Black/African American: 5/179, 2.8%",17.8 ± 2.8,"8/118, 7%","45/118, 38%","54/118, 46%",0.2 ± 0.04,1.2 ± 0.1,0.005 ± 0.007,−0.6 ± 1.1
FHS,2682,56.0 ± 13.6,"1437/2682, 54%","Non‐Hispanic White: 1754/2682, 65%;Black/African American: 0/2682, 0%;Hispanic ethnicity: not collected","No high school: 19/2682, 0.7%High school: 420/2682, 15%College: 2243/2682, 84%","193/2682, 7%","884/2682, 33%","200/2682, 7%",0.2 ± 0.03,1.3 ± 0.1,0.002 ± 0.004,−0.2 ± 0.7
